ucsf logo

Ramani Chaganti, MD

Rheumatology • Internal Medicine
Rheumatology Parnassus
415-353-2497
ucsf logo

Ramani Chaganti, MD

Rheumatology • Internal Medicine
Rheumatology Parnassus
415-353-2497

On this page

Education & training

Board certification

  • Rheumatology, American Board of Internal Medicine/Rheumatology

Fellowship

  • Rheumatology, Hospital for Special Surgery

Residency

  • Internal Medicine, Temple University Hospital - Main Campus

Internship

  • Internal Medicine, Temple University Hospital - Main Campus

Degree

  • MD, Temple University

Academic title

  • Health Sciences Clinical Professor

My expertise

Locations

    Reviews

    Average rating

    5
    5 out of 5 Stars
    148 ratings
    About provider reviews

    Showing 1-6 of 44 reviews

    Sort by
    • 5 out of 5 Stars
      July 8, 2026

      Dr. Chaganti is EXCELLENT

    • 5 out of 5 Stars
      March 30, 2026

      Dr Chaganti is an exceptional doctor. One of the Best.

    • 5 out of 5 Stars
      March 20, 2026

      Dr. Chaganti is always the epitome of professionalism and compassion.

    • 5 out of 5 Stars
      March 6, 2026

      Dr Chaganti is a valuable asset to the staff of UCSF. She has been by Rheumatologist going on 16 yrs. She is a natural healer who cares highly of her patients.

    • 5 out of 5 Stars
      February 28, 2026

      Dr. Chaganti is an absolutely stellar physician. Her expertise is amazing and I totally trust her advice.

    • 5 out of 5 Stars
      February 13, 2026

      Absolutely wonderful doctor, spent a lot of time going over everything

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.